1 Min Read
April 5 (Reuters) - Fortress Biotech Inc:
* Fortress biotech announces orphan drug designations for cael-101 in amyloidosis Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.